DXT — Dexterra Income Statement
0.000.00%
Last trade - 00:00
- CA$378.47m
- CA$495.95m
- CA$1.12bn
- 93
- 94
- 69
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 458 | 471 | 733 | 972 | 1,117 |
Cost of Revenue | |||||
Gross Profit | 8.7 | 60 | 102 | 103 | 143 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 563 | 391 | 697 | 961 | 1,070 |
Operating Profit | -105 | 80.6 | 36 | 10.1 | 47.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -112 | 76.7 | 33.3 | 3.22 | 35.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -84.8 | 64.5 | 24.6 | 3.71 | 26.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -84.8 | 64 | 24.4 | 3.43 | 26.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -84.8 | 64 | 24.4 | 3.43 | 26.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.894 | 0.119 | 0.286 | 0.199 | 0.496 |
Dividends per Share |